Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Perifosine

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Perifosine?

Perifosine is an investigational drug.

There have been 43 clinical trials for Perifosine. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1^st 2009.

The most common disease conditions in clinical trials are Multiple Myeloma, Neoplasms, Plasma Cell, and Leukemia. The leading clinical trial sponsors are AEterna Zentaris, National Cancer Institute (NCI), and Dana-Farber Cancer Institute.

Summary for Perifosine

US Patents	0
International Patents	0
US Patent Applications	5,539
WIPO Patent Applications	133
Japanese Patent Applications	1,180
Clinical Trial Progress	Phase 3 (2009-12-01)
Vendors	92

Recent Clinical Trials for Perifosine

Title	Sponsor	Phase
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas	AEterna Zentaris	Phase 1
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas	Pfizer	Phase 1
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas	Andrew B Lassman, MD	Phase 1

See all Perifosine clinical trials

Clinical Trial Summary for Perifosine

Top disease conditions for Perifosine

Top clinical trial sponsors for Perifosine

See all Perifosine clinical trials

US Patents for Perifosine

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Baxter

Johnson and Johnson

Moodys

Medtronic

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.